Foresite Capital Management Ii, LLC Uni Qure N.V. Transaction History
Foresite Capital Management Ii, LLC
- $29.2 Million
- Q3 2023
Shares
2 transactions
Others Institutions Holding QURE
# of Institutions
148Shares Held
34.1MCall Options Held
1.07MPut Options Held
603K-
Vestal Point Capital, LP New York, NY4.73MShares$18.1 Million2.03% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.09MShares$11.9 Million1.03% of portfolio
-
683 Capital Management, LLC New York, NY1.98MShares$7.58 Million0.88% of portfolio
-
Black Rock Inc. New York, NY1.86MShares$7.15 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.52MShares$5.83 Million0.0% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $179M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...